CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model: Evidence for Hematopoietic Chimerism

Transplantation

Volumn 61, Issue 7, 1996, Pages 997-1004

  Pearson, Thomas C ^a,c   Alexander, Diane Z ^a   Hendrix, Rose ^a   Elwood, Eric T ^a   Linsley, Peter S ^b   Winn, Kevin J ^a   Larsen, Christian P ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN GRAFT;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; CYTOKINES; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RADIATION TOLERANCE; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029944669     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00002     Document Type: Article

References (44)

1. Monaco AP, Wood ML. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunological tolerance with ALS. Transplant Proc 1970; 2: 489.
2. Mayumi H, Good RA. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med 1990; 169: 213.
3. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
4. Qin S, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 779.
5. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
6. McDaniel DO, Naftilan J, Hulvey K, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 1994; 57: 852.
7. Suberbielle C, Caillat-Zucman S, Legendre C, et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet 1994; 343: 1468.
8. Liu Y, Linsley PS. Costimulation of T-cell growth. Curr Opin Immunol 1992; 4: 265.
9. Boussiotis VA, Freeman GJ, Gray G, Gribben J, Nadler LM. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. J Exp Med 1993; 178: 1753.
10. Linsley PS, Brady W, Urnes M, Grosmaire L, Damle N, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
11. Tan P, Anasetti C, Hansen JA, et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993; 177: 165.
12. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992; 176: 1215.
13. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
14. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4-Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
15. Lenschow D, Zeng Y, Thistlethwaite J, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
16. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4-Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
17. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57: 1701.
18. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non H-2 antigens in rejection. Transplantation 1973; 16: 343.
19. Billingham RE, Medawar PB. Technique of free skin grafting in mammals. J Exp Biol 1951; 28: 385.
20. Armitage P, Berry G. Statistical methods in medical research, 2nd ed. Oxford: Blackwell, 1987.
21. Brecher G, Ansel J, Micklem H, Tijo J, Cronkite E. Special proliferative sites are not needed for seeing and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci USA 1982; 79: 5085.
22. Chen W, Cheever MA. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression. J Immunol 1994; 152: 4767.
23. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993; 81: 2566.
24. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993; 328: 745.
25. Bushell A, Pearson T, Morris P, Wood K. Donor-recipient microchimerism is not required for adult induced transplantation tolerance. Transplantation 1995; 59: 1367.
26. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
27. Fabre JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 1972; 14: 608.
28. Salgame P, Abrams J, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279.
29. Takeuchi T, Lowry R, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-line effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
30. Lu P, di Zhou X, Chen SJ, et al. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med 1994; 180: 693.
31. Corry DB, Reiner SL, Linsley PS, Locksley RM. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental Leishmania. J Immunol 1994; 153: 4142.
32. Larsen CP, Alexander DZ, Hendrix R, Ritchie SC, Pearson TC. Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses? Transplantation 1995; 60: 221.
33. Griffiths GM, Mueller C. Expression of perform and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells [review]. Immunol Today 1991; 12: 415.
34. Lipman ML, Stevens AC, Bleackley RC, et al. The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992; 53: 73.
35. Bugeon L, Cuturi MC, Paineau J, Anegon I, Soulillou JP. Similar levels of granzyme A and perform mRNA expression in rejected and tolerated heart allografts in donor-specific tolerance in rats. Transplantation 1993; 56: 405.
36. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med 1987; 165: 566.
37. Cuturi MC, Josien R, Douillard P, et al. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the α1 helix of the first domain of HLA-B7 01. Transplantation 1995; 59: 661.
38. Ju S-T, Panka DJ, Cui H, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444.
39. Montgomery RA, Dallman MJ. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 1991; 147: 554.
40. Benoist CO, Mathis DJ, Kanter MR, Williams VED, McDevitt HO. Regions of allelic hypervariability in the murine A alpha immune response gene. Cell 1983; 34: 169.
41. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularized organ grafts: analysis using semi-quantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
42. O'Connell P, Pacheco-Silva A, Nickerson P, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
43. Shinkai Y, Takio K, Okumura K. Homology of perform to the ninth component of complement. Nature 1988; 334: 525.
44. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969.